1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY, CA
Market cap: $3.6B (12/18/2025)
Price: $39.90
Announces Pricing of Upsized $650 Million Public Offering
Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701’s Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting
Earnings Release
Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML
Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist in Obesity
Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
Shareholder votes
Annual Report to Security Holders
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report